NEWARK, N.J., March 5, 2020 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.2 million and a loss per diluted share of $0.08 for the fiscal quarter ended January 31, 2020.

MONMOUTH JUNCTION, N.J., March 5, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy leader commercializing its

NEW YORK and BOSTON, March 5, 2020 /PRNewswire/ -- Royalty Pharma announced today that it has acquired Massachusetts General Hospital's (MGH) royalty interest in Entyvio (vedolizumab) for $94 million. Entyvio is a monoclonal antibody that is used in the treatment of ulcerative colitis and Crohn's disease

MCKINNEY, Texas, March 5, 2020 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) announced that its Board of Directors has raised the quarterly dividend to $.1875 per share on all of the outstanding common stock of the Company held of record as of the close of business of the Company's transfer agent on April 3, 2

AUSTIN, Texas, March 5, 2020 /PRNewswire/ -- Choose Health, a physician-developed health testing and tracking service, has unveiled their pilot product, the

NASHVILLE, Tenn., March 5, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), a global leader in life sciences solutions, today announced financial results for the three and twelve-month periods ended December 31, 2019.

HOUSTON, March 5, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, plans to report financial results for the three and 12 months ended December

SILVER SPRING, Md., March 5, 2020 /PRNewswire/ -- Over the past year, the U.S. Food and Drug Administration has embarked on a comprehensive evaluation of cannabidiol (CBD) products, with a focus on educating the public about the risks and unknowns of these products, gathering the science needed to better understand both these safety concerns and potential benefits t

CAMBRIDGE, Mass., March 5, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living med

SAN DIEGO and CALGARY, Alberta, March 5, 2020 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced its financial results and operational highlights for the quarter and year ended Dec